As shown in Table 3, fourteen overlapping targets (GSK3B, MAPK1, HSPA8, VEGFA, FGF2, MTOR, and so on) were considered potential targets for the treatment of melanoma with salidroside (Figure 1C). This evidence concerns the gene FGF2 and melanoma.